112 related articles for article (PubMed ID: 33109555)
1. Breast Cancer Cells Induce a Pro-inflammatory Response to Mitigate Immune Mediation in a 3D Culture Model.
Augustine TN; Duarte R; Candy GP
Anticancer Res; 2020 Nov; 40(11):6179-6193. PubMed ID: 33109555
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a heterotypic 3D culture system to evaluate the interaction of TREG lymphocytes and NK cells with breast cancer.
Augustine TN; Dix-Peek T; Duarte R; Candy GP
J Immunol Methods; 2015 Nov; 426():1-13. PubMed ID: 26215372
[TBL] [Abstract][Full Text] [Related]
3. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
4. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
Qu X; Tang Y; Hua S
Front Immunol; 2018; 9():563. PubMed ID: 29662489
[TBL] [Abstract][Full Text] [Related]
5. 3D extracellular matrix interactions modulate tumour cell growth, invasion and angiogenesis in engineered tumour microenvironments.
Taubenberger AV; Bray LJ; Haller B; Shaposhnykov A; Binner M; Freudenberg U; Guck J; Werner C
Acta Biomater; 2016 May; 36():73-85. PubMed ID: 26971667
[TBL] [Abstract][Full Text] [Related]
6. Is TGFβ as an anti-inflammatory cytokine required for differentiation of inflammatory T
Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
J Immunotoxicol; 2016 Nov; 13(6):775-783. PubMed ID: 27754729
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
8. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
Song W; Thakor P; Vesey DA; Gobe GC; Morais C
Biomed Pharmacother; 2018 Oct; 106():247-254. PubMed ID: 29966967
[TBL] [Abstract][Full Text] [Related]
9. Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
Sabry M; Zubiak A; Hood SP; Simmonds P; Arellano-Ballestero H; Cournoyer E; Mashar M; Pockley AG; Lowdell MW
PLoS One; 2019; 14(6):e0218674. PubMed ID: 31242243
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells.
He S; Li M; Ma X; Lin J; Li D
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2621-30. PubMed ID: 20930173
[TBL] [Abstract][Full Text] [Related]
11. The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes.
Duechler M; Peczek L; Zuk K; Zalesna I; Jeziorski A; Czyz M
Immunobiology; 2014 Feb; 219(2):158-65. PubMed ID: 24091277
[TBL] [Abstract][Full Text] [Related]
12. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
13. Modeling breast acini in tissue culture for detection of malignant phenotype reversion to non-malignant phenotype.
Vahidnezhad H; Youssefian L; Jeddi-Tehrani M; Akhondi MM; Rabbani H; Shokri F; Tabrizi M
Iran Biomed J; 2009 Oct; 13(4):191-8. PubMed ID: 19946344
[TBL] [Abstract][Full Text] [Related]
14. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
[TBL] [Abstract][Full Text] [Related]
15. 3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic response.
Gangadhara S; Smith C; Barrett-Lee P; Hiscox S
BMC Cancer; 2016 Jun; 16():345. PubMed ID: 27251376
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
[TBL] [Abstract][Full Text] [Related]
18. Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.
Joffroy CM; Buck MB; Stope MB; Popp SL; Pfizenmaier K; Knabbe C
Cancer Res; 2010 Feb; 70(4):1314-22. PubMed ID: 20145137
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients.
Chew V; Tow C; Teo M; Wong HL; Chan J; Gehring A; Loh M; Bolze A; Quek R; Lee VK; Lee KH; Abastado JP; Toh HC; Nardin A
J Hepatol; 2010 Mar; 52(3):370-9. PubMed ID: 19720422
[TBL] [Abstract][Full Text] [Related]
20. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
